INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PA

Perez Daniel Antonio

Director, CEO & Co-Founder, 10% OwnerCIK 0002063236

EDGAR filingsOpen in network
Disclosed transactions41
Buys / sells0 / 18
Max Insider Score29
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
4,100 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Hinge Health, Inc.Director, CEO & Co-Founder, 10% Owner · Dec 12, 2025
21
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL
$411K
4,100 sh
Oct 6, 2026
Oct 7, 2026
traded Oct 6, 2026
+1d
SEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
4,100 sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

4
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
145.0K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$149K
1,630 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

25
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$1.61M
17.7K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

25
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3.29M
37.3K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

29
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$5.23M
58.1K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

25
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.19M
24.6K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

21
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.15M
24.4K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
145.0K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

25
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3.14M
35.3K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Gift · 10b5-1 plan
G—
45.0K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

4
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
150.0K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$101K
1,100 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

18
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$652K
7,171 sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

25
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$3.85M
42.7K sh
Sep 10, 2026Sep 11, 2026
traded Sep 10, 2026
+1dSEC FORM 4

Evidence

7
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
104.5K sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC FORM 4

Evidence

4
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
45.5K sh
May 7, 2026May 8, 2026
traded May 7, 2026
+1dSEC FORM 4

Evidence

3
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
104.5K sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
45.4K sh
May 7, 2026May 8, 2026
traded May 7, 2026
+1dSEC FORM 4

Evidence

27
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$5.76M
104.5K sh
May 6, 2026May 8, 2026
traded May 6, 2026
+2dSEC FORM 4

Evidence

24
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.50M
45.5K sh
May 7, 2026May 8, 2026
traded May 7, 2026
+1dSEC FORM 4

Evidence

5
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion
C—
7,260 sh
Feb 17, 2026Feb 18, 2026
traded Feb 17, 2026
+1dSEC FORM 4

Evidence

13
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion
C—
7,260 sh
Feb 17, 2026Feb 18, 2026
traded Feb 17, 2026
+1dSEC FORM 4

Evidence

16
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Gift
G—
7,260 sh
Feb 17, 2026Feb 18, 2026
traded Feb 17, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$6.71M
166.7K sh
Feb 12, 2026Feb 13, 2026
traded Feb 12, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$2.07M
44.3K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

22
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$5.66M
122.4K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC FORM 4

Evidence

23
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$267K
5,420 sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

0
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

26
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Open-market sale · 10b5-1 plan
SELL$7.82M
161.3K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

11
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion · 10b5-1 plan
C—
166.7K sh
Dec 15, 2025Dec 16, 2025
traded Dec 15, 2025
+1dSEC FORM 4

Evidence

9
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion
C—
11.7K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence

12
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Gift
G—
11.7K sh
Dec 12, 2025Dec 12, 2025
traded Dec 12, 2025
+0dSEC FORM 4

Evidence

9
PA
Perez Daniel AntonioDirector, CEO & Co-Founder, 10% Owner
HNGEHinge Health, Inc.
Derivative conversion
C—
11.7K sh
Dec 10, 2025Dec 12, 2025
traded Dec 10, 2025
+2dSEC FORM 4

Evidence